United States · FDA National Drug Code directory
Sirolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6197_5fb6d644-aae8-0bcc-d9ce-170dff1c4b44
- Product NDC
- 60505-6197
- Form
- SOLUTION
- Composition / generic term
- SIROLIMUS
- Labeler
- Apotex Corp
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200520
- Source listing expiry
- 20261231
Source-listed ingredients
- SIROLIMUS — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (60505-6197-2) / 60 mL in 1 BOTTLE, GLASS · 60505-6197-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →